Keep Your Eye on Us for New and Exciting Content
Now that our new site is LIVE, keep checking in! We have tons of new information and videos in the pipeline to share with you! From our partnership with Haalthy, to the newest information from ASCO, to the introduction of new cancer types, new board members, and new programs, we are gearing up for a very busy and exciting year. Thanks for being a part of GRACE!
Featured Content
Join us for this Free Webinar on Saturday, December 14, 2024 8:00 AM - 10:30 AM Pacific, 11 AM - 1:30 PM Eastern This live, virtual, interactive patient education event includes presentations and panel discussions covering general subjects relevant to a diverse range of lung cancers and treatment options and an opportunity to speak with the experts in a Q&A session. Speakers include top medical professionals presenting patient-focused discussions to educate the patient and caregiver communities...
Join us for this Free Webinar on Saturday, December 14, 2024 8:00 AM - 10:30 AM Pacific, 11 AM - 1:30 PM Eastern This live, virtual, interactive patient education event includes presentations and panel discussions covering general subjects relevant to a diverse range of lung cancers and treatment options and an opportunity to speak with the experts in a Q&A session. Speakers include top medical professionals presenting patient-focused discussions to educate the patient and caregiver communities...
Join us for this Free Webinar on Saturday, October 12, 2024 8:00 AM - 10:45 AM Pacific, 11 AM - 1:45 PM Eastern This live, virtual, interactive patient education event includes presentations and panel discussions covering general subjects relevant to a diverse range of blood cancers and treatment options and an opportunity to speak with the experts in a Q&A session. Speakers include top medical professionals presenting patient-focused discussions to educate the patient and caregiver communities...
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Registration is now open! Join us for the annual 2024 Blood Cancers OncTalk! Register Now! This live, virtual, interactive patient education event includes presentations and panel discussions covering general subjects relevant to a diverse range of blood cancers and treatment options, as well as an opportunity to speak with the experts in a Q&A session. Speakers includes top medical professionals presenting patient-focused discussions to educate the patient and caregiver communities to become...
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…